LIVE: CBSE exams 2021 from May 4, results by July 15, says minister
Latest live news updates: The Central Board of Secondary Education (CBSE) will conduct classes 10 and 12 exams from May...
Business Economics
Analyzing the Cost Savings and Economic Benefits of Gigamon
Digital transformation initiatives are prompting organizations to adopt modern IT infrastructures to improve organizational efficiencies and customer experiences. The COVID-19...
The Vanguard 529—a premier plan that’s setting the pace
A proven brand partner Fortunately, The Vanguard 529 Plan has been future-focused all along. We’re committed to offering a premier...
Agri-tech startup Aqgromalin raises ₹2 crore from angel investors
Agri-tech startup Aqgromalin said it has raised ₹2 crore from angel investors participating from the Middle East.The company aims to...
New solutions help local public adm… – Information Centre – Research & Innovation
Cyberattacks against local governments are on the rise. To help fight back, an EU-funded project has developed and tested a...
U.S. government agrees to purchase 100 million additional Pfizer vaccines
The Department of Health and Human Services with the Department of Defense today announced they will purchase another 100 million...
Gamification at work creates winners and losers
Even before Covid-19 forced employees to work from home, many businesses were moving to more remote working. While this offers...
Atos delivers its first GPU-accelerated Quantum Learning Machine to the Irish Centre for High-End Computing (ICHEC)
Dublin, Ireland and Paris, France - 17 December 2020Atos today announces it will deliver its first GPU-accelerated Atos Quantum Learning...
Coke to Cut 2,200 Jobs Amid Virus Slowdown
Coca-Cola is planning to cut 2,200 jobs, including 1,200 in the U.S., as it continues to regroup from declining sales...
Pfizer-BioNTech Covid-19 Vaccine Is Cleared for Use by EU Drug Agency
BRUSSELS—The Covid-19 vaccine from Pfizer Inc. and its German partner BioNTech SE was cleared for use by the European Union’s...
